ReviewNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2019

Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond.

Anna M Krichevsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.